How to buy Fulcrum Therapeutics shares

Fulcrum Therapeutics Inc (FULC) is a publicly traded biotechnology business based in the US. On 13 September Fulcrum Therapeutics shares plunged 9.00% to a closing position of $4.75. However, over the last 12 months, Fulcrum Therapeutics's share price has risen by 23.07% from $8.15. Fulcrum Therapeutics is listed on the NASDAQ and employs 89 staff. All prices are listed in US Dollars.

Our top picks for where to buy Fulcrum Therapeutics shares:

Best for

0% commission

Best for

Beginner investments

Best for

Beginners

Best for

Low fees

Fees for buying 100x Fulcrum Therapeutics shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform	Customer rating	Platform fee	Min. initial deposit	Trading fee estimate
	★★★★★	£0 - £9.99	No minimum	£4.82 £822.17 total	Go to site Capital at risk
	★★★★★	£0	$50	£4.09 £821.43 total	Go to site Capital at risk
	★★★★★	£0	£250	£12.28 £829.62 total	Go to site Capital at risk
	Not yet rated	£0	No minimum	£4.09 £821.43 total	Go to site Capital at risk
	Not yet rated	£0	No minimum	£4.09 £821.43 total	Go to site Capital at risk
	★★★★★	£0	£1	£20.12 £837.47 total	Go to site Capital at risk
	Not yet rated	£0	No minimum	£2.94 £820.29 total	Go to site Capital at risk

Full comparison of share dealing platforms

Alternative ways to invest in Fulcrum Therapeutics

• Invest in Fulcrum Therapeutics via a fund

  Buying shares in just one company can leave you more exposed to unexpected swings in the market than if you have a range of investments - a "diversified portfolio". Experts generally recommend having a broad mix of assets and funds that hold a ready-made portfolio of at least 50 different companies' shares, on the basis that drops in the value of some will be offset by rises elsewhere.

  Fulcrum Therapeutics is a major part of the NASDAQ index, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).

Is it a good time to buy Fulcrum Therapeutics stock?

Only you can make the decision on the time to leap. The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.

Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.

• See the technical analysis gauge

• See Fulcrum Therapeutics share price (NASDAQ:FULC)

  Use our graph to track the performance of FULC stocks over time.

  Share price volatility

  Over the last 12 months, Fulcrum Therapeutics's shares have ranged in value from as little as $2.25 up to $15. A popular way to gauge a stock's volatility is its "beta".

  Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Fulcrum Therapeutics's is 2.1282. This would suggest that Fulcrum Therapeutics's shares are significantly more volatile than the average for this exchange and represent a higher risk.

• What's Fulcrum Therapeutics price performance over time?

  Historical closes compared with the last close of $10.03

  1 week (2023-09-15)	123.39%
  1 month (2023-08-22)	84.71%
  3 months (2023-06-22)	213.44%
  6 months (2023-03-22)	200.30%
  1 year (2022-09-22)	22.02%
  2 years (2021-09-22)	-64.91%
  3 years (2020-09-22)	23.83%

Invest in Fulcrum Therapeutics shares

Finder Award

• Start investing from $50
• Pay no stamp duty on UK shares
• Commission-free trading. Other fees may apply.

Go to site

Capital at risk

Frequently asked questions

• Does Fulcrum Therapeutics pay dividends?

  We're not expecting Fulcrum Therapeutics to pay a dividend over the next 12 months. Typically it's companies that have been around for longer that pay dividends (Fulcrum Therapeutics had its IPO on 18 July 2019). However, you can browse other dividend-paying shares in our guide.

  Currently 1.583% of Fulcrum Therapeutics shares are held by insiders and 98.735% by institutions.

• How many people work for Fulcrum Therapeutics?

  Latest data suggests 89 work at Fulcrum Therapeutics.

• When does the fiscal year end for Fulcrum Therapeutics?

  Fulcrum Therapeutics's fiscal year ends in December.

• Where is Fulcrum Therapeutics based?

  Fulcrum Therapeutics's address is: 26 Landsdowne Street, Cambridge, MA, United States, 02139

• What is Fulcrum Therapeutics's ISIN number?

  Fulcrum Therapeutics's international securities identification number is: US3596161097

• What is Fulcrum Therapeutics's CUSIP number?

  Fulcrum Therapeutics's Committee on Uniform Securities Identification Procedures number is: 359616109

• How to sell Fulcrum Therapeutics shares

  It's as easy to sell Fulcrum Therapeutics as it is to buy! Here's how to sell Fulcrum Therapeutics that you already own.

  1. Open your investment app. If you've got one with desktop access, you can log in online
  2. Go to your portfolio. This should be in the main menu
  3. Find your shares. You may be able to search your portfolio
  4. Choose how many you'd like to sell. You'll be able to review the price and see how much you'll receive
  5. Sell your Fulcrum Therapeutics shares. Your investment platform will let you know when your shares are sold

• Can you buy Fulcrum Therapeutics shares with a debit card?

  Most share dealing providers in the UK will let you use your debit card to top up your account and buy shares. The main ways are with a debit card, bank transfer or with Apple/Google Pay.

• What's the easiest way to buy Fulcrum Therapeutics shares?

  The easiest way to get hold of some Fulcrum Therapeutics shares is to sign up for a share trading app and place a market order or basic order. This type of order tells the platform that you're interested, so it'll try to execute it as quickly as it can. It could take some time for the order to go through, especially if there's a lot of volatility in Fulcrum Therapeutics shares.

• Do you need to complete a W8-BEN form if you want to invest in Fulcrum Therapeutics

  If you're investing in a US stock, you'll need to complete a W8-BEN form to minimise your tax liability. Whether these are automatically handled for you depends on your broker, so it would be a good idea to check with them directly.

• What is the key financial information for Fulcrum Therapeutics?

  Financials

  Revenue TTM	$3 million
  Gross profit TTM	$-70,440,000
  Return on assets TTM	-27.02%
  Return on equity TTM	-45.13%
  Profit margin	0%
  Book value	$4.455
  Market capitalisation	$353.6 million

  TTM: trailing 12 months